References
- Ito T, Kwon H, Zimdahl B, et al. Regulation of myeloid leukemia by the cell fate determinant Musashi. Nature 2010;466:765–768.
- Kharas M, Lengner C, Al-Shahrour F, et al. Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat Med 2010;16:903–908.
- Mu Q, Wang Y, Chen B, et al. High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia. Leuk Res 2013;37:922–927.
- Byers R, Currie T, Tholouli E, et al. MSI2 protein expression predicts unfavorable outcome in acute myeloid leukemia. Blood 2011;118: 2857–2867.
- Barbouti A, Hoglund M, Johansson B, et al. A novel gene, MSI2, encoding a putative RNA- binding protein is recurrently rearranged at disease progression of chronic myeloid leukemia and forms a fusion gene with HOXA9 as a result of the cryptic t(7;17)(p15;q23). Cancer Res 2003;63:1202–1206.
- Weer A, Speleman F, Cauwelier B, et al. EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22. Haematologica 2008;93:1903–1907.
- Cools J, Wlodarska I, Somers R, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes, Chromosomes Cancer 2002;34:354–362.
- Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004;204:489–505.
- Adams S, Aydin I, Celebi J. GAB2 - a scaffolding protein in cancer. Mol Cancer Res 2012;10:1265–1270.